-
Mashup Score: 0
This episode covers the clearance of 2 new OTC CGMs from Abbott, JDRF becoming Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with T1D
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
This episode covers the clearance of 2 new OTC CGMs from Abbott, JDRF becoming Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with T1D
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
The latest #DiabetesDialogue is now live! Get caught up with news in diabetes technology, including new OTC CGMs and CamAPS FX, and the renaming of JDRF to @BreakthroughT1D. https://t.co/uqzquHlfJe
-
-
Mashup Score: 2Endocrinology Month in Review: March 2024 - 1 year(s) ago
In this endocrinology month in review for March 2024, we recap the most popular FDA news and pipeline updates as well as recognizing the 2-year anniversary of Diabetes Dialogue.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Need to catch up on all the endocrinology and diabetes-related headlines from March 2024? Our endocrinology month in review has you covered with a recap of FDA news, pipeline updates, and a collection of #DiabetesDialogue episodes from the last month! https://t.co/3huoL1PJEe https://t.co/TVwqPb2AN1
-
-
Mashup Score: 4
Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
The latest #DiabetesDialogue is now live! Learn more about the utility of time in range and other advanced CGM metrics with @DianaMIsaacs and @Natalie_Bellini as well as @DrViralShah. https://t.co/OMOOS781pI https://t.co/PtklxRLj5r
-
-
Mashup Score: 0Diabetes Dialogue: 2023 Top Episodes Recap - 1 year(s) ago
To celebrate the end of 2023, hosts recap the top 10 episodes of the past year and offer perspective on how the news discussed in these episodes has shaped the future of diabetes management.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Our end of year recap for #DiabetesDialogue spotlighted the 10 most popular episodes from 2023. In this preview hosts discuss the second most popular episode, which focused on TRANSITION-T2D. https://t.co/QOxuMbM4JL https://t.co/QiEgrAWyh0
-
-
Mashup Score: 5
In this episode, hosts discuss the FDA clearance of the Omnipod 5 App for iPhones and a pair of studies examining use of automated insulin delivery systems.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
In the latest #DiabetesDialogue, @DianaMIsaacs and @Natalie_Bellini break down the latest in diabetes tech from the month of October. In this preview, hosts discuss the impact of the clearance of the Omnipod 5 App for iPhones. Learn more: https://t.co/GgoVFWry1J https://t.co/gnvJ7v7nEb
-
-
Mashup Score: 0Diabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD - 2 year(s) ago
At ADA 2023, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sat down with ADCES President-Elect Jane Dickinson, RN, PhD, to discuss her work to address shortfalls of the current language used in the management of diabetes.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: At ADA 2023, #DiabetesDialogue sat down with @JaneKDickinson to discuss efforts to reform language around metabolic disease. https://t.co/1i7xVymg8q https://t.co/wBW817H1Ea
-
-
Mashup Score: 0Diabetes Dialogue: Tandem Mobi and Welldoc's BlueStar Platform - 2 year(s) ago
In this episode, hosts discuss their experience interacting with the Tandem Mobi pump from the ADCES 2023 meeting and offer perspective on what the Welldoc clearances mean for people with diabetes and care providers.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
The latest #DiabetesDialogue features a discussion on the @TandemDiabetes Mobi insulin pump and the FDA clearance of @Welldoc's BlueStar. https://t.co/8GNJvCFEci #Diabetes @DianaMIsaacs @natalie_bellini https://t.co/WO6XQx5kYj
-
-
Mashup Score: 0Diabetes Dialogue: Tandem Mobi and Welldoc's BlueStar Platform - 2 year(s) ago
In this episode, hosts discuss their experience interacting with the Tandem Mobi pump from the ADCES 2023 meeting and offer perspective on what the Welldoc clearances mean for people with diabetes and care providers.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Check out the latest episode of #DiabetesDialogue where hosts discuss the @TandemDiabetes Mobi insulin pump and the FDA clearance of the BlueStar platform from @Welldoc. https://t.co/8GNJvCFEci #Diabetes https://t.co/Cs6dMclFdW
-
-
Mashup Score: 4
In this special edition episode, hosts break down what the announcement of the 10 drugs selected for Medicare price negotiations under the Inflation Reduction Act means for providers and people with diabetes.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
In this special edition episode of #DiabetesDialogue, @DianaMIsaacs and @Natalie_Bellini break down what the @HHSgov announcement of the 10 drugs selected for #Medicare price negotiations means for providers and people with #diabetes. https://t.co/SBNQ4M8PAE https://t.co/F1HKGx1sKn
-
The latest #DiabetesDialogue is now live! Get caught up with news in diabetes technology, including new OTC CGMs and CamAPS FX, and the renaming of JDRF to @BreakthroughT1D. https://t.co/uqzquHlfJe